This site is intended for healthcare professionals

CHMP recommends extending the indication for Remsima SC to include Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and psoriasis.- Celltrion Healthcare

Read time: 1 mins
Last updated:29th Jun 2020
Published:28th Jun 2020
Condition: Rheumatoid Arthritis
Type: drug
Register free for full access to